The President of the United States recently visited the Centers for Disease Control and Prevention (CDC), focused on the control of the spread of Covid-19. Speaking in a lab at the CDC, CSBio's peptide synthesizers can be seen behind the President and team.
Read more...CSBio invests $1,500,00 USD in NervGen, a regenerative medicine company dedicated to creating innovative solutions for the treatment of nerve damage.
Read more...With the release of CSBio's novel oligonucleotide synthesizers that allow for batch synthesis and optimized for polystyrene resin, CSBio has partnered with Sun Resin to specifically develop an optimized polystyrene resin for commercial scale oligonucleotide synthesis.
Read more...In this article, we explore the peptide research around the world focused on defeating coronavirus.
Read more...In this case study, we talk about CSBio's peptide synthesizer platform and knowledge that allows companies to utilize our peptide synthesizers during the early days of drug discovery, all way through commerical scale manufacturing
Read more...Using a CSBio research scale peptide synthesizer, we share a case study of how a 132-mer peptide can be synthesized with high purity
Read more...CSBio is a leading peptide and instrumentation manufacturing company located on the edge of Silicon Valley in Menlo Park, California.
CSBio provides nonGMP and cGMP peptides, peptide APIs, research scale peptide synthesizers, commerical scale peptide synthesizers, DNA/RNA oligonucleotide synthesizers, and preparative HPLC purification equipment.